Magis-Escurra C - Search Results

1

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.

Boeree MJ, Diacon AH, Dawson R, Narunsky K, du Bois J, Venter A, Phillips PP, Gillespie SH, McHugh TD, Hoelscher M, Heinrich N, Rehal S, van Soolingen D, van Ingen J, Magis-Escurra C, Burger D, Plemper van Balen G, Aarnoutse RE; PanACEA Consortium. Boeree MJ, et al. Am J Respir Crit Care Med. 2015 May 1;191(9):1058-65. doi: 10.1164/rccm.201407-1264OC. Am J Respir Crit Care Med. 2015. PMID: 25654354 Clinical Trial.

2

Mycobacterium xenopi clinical relevance and determinants, the Netherlands.

van Ingen J, Boeree MJ, de Lange WC, Hoefsloot W, Bendien SA, Magis-Escurra C, Dekhuijzen R, van Soolingen D. van Ingen J, et al. Emerg Infect Dis. 2008 Mar;14(3):385-9. doi: 10.3201/eid1403.061393. Emerg Infect Dis. 2008. PMID: 18325251 Free PMC article.

3

[Characteristics and treatment of tuberculosis patients in Dekkerswald, 2000-2005].

Magis-Escurra C, Miedema JR, de Lange WC, van Ingen J, Dekhuijzen PN, Boeree MJ. Magis-Escurra C, et al. Ned Tijdschr Geneeskd. 2008 Mar 15;152(11):622-6. Ned Tijdschr Geneeskd. 2008. PMID: 18410023 Dutch.

4

Surgical treatment of non-tuberculous mycobacterial lung disease: strike in time.

van Ingen J, Verhagen AF, Dekhuijzen PN, van Soolingen D, Magis-Escurra C, Boeree MJ, de Lange WC. van Ingen J, et al. Int J Tuberc Lung Dis. 2010 Jan;14(1):99-105. Int J Tuberc Lung Dis. 2010. PMID: 20003702

5

Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis.

Burger DM, Magis-Escurra C, van den Berk GE, Gelinck LB. Burger DM, et al. AIDS. 2010 Jan 16;24(2):328-30. doi: 10.1097/QAD.0b013e3283350f08. AIDS. 2010. PMID: 20029272 No abstract available.

6

[Nontuberculous mycobacteria: clinically relevant].

van Ingen J, Hoefsloot W, de Lange WC, Magis-Escurra C, Dekhuijzen PN, Boeree MJ, van Soolingen D. van Ingen J, et al. Ned Tijdschr Geneeskd. 2010;154:A1178. Ned Tijdschr Geneeskd. 2010. PMID: 20482903 Review. Dutch.

7

The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.

van Soolingen D, Hernandez-Pando R, Orozco H, Aguilar D, Magis-Escurra C, Amaral L, van Ingen J, Boeree MJ. van Soolingen D, et al. PLoS One. 2010 Sep 9;5(9):e12640. doi: 10.1371/journal.pone.0012640. PLoS One. 2010. PMID: 20844587 Free PMC article.

8

Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007.

Majoor CJ, Magis-Escurra C, van Ingen J, Boeree MJ, van Soolingen D. Majoor CJ, et al. Emerg Infect Dis. 2011 Mar;17(3):457-63. doi: 10.3201/eid1703.101111. Emerg Infect Dis. 2011. PMID: 21392437 Free PMC article.

9

Therapeutic drug monitoring in the treatment of tuberculosis patients.

Magis-Escurra C, van den Boogaard J, Ijdema D, Boeree M, Aarnoutse R. Magis-Escurra C, et al. Pulm Pharmacol Ther. 2012 Feb;25(1):83-6. doi: 10.1016/j.pupt.2011.12.001. Epub 2011 Dec 11. Pulm Pharmacol Ther. 2012. PMID: 22179055

10

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases.

Hoefsloot W, van Ingen J, Peters EJ, Magis-Escurra C, Dekhuijzen PN, Boeree MJ, van Soolingen D. Hoefsloot W, et al. Clin Microbiol Infect. 2013 May;19(5):432-7. doi: 10.1111/j.1469-0691.2012.03817.x. Epub 2012 Mar 22. Clin Microbiol Infect. 2013. PMID: 22439918 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters